期刊文献+

呼吸道药物递送—雾化吸入剂的研究进展 被引量:44

Pulmonary delivery drugs:developments in nebulizers
在线阅读 下载PDF
导出
摘要 吸入给药是防治哮喘、慢性阻塞性肺疾病(COPD)等呼吸道疾病的首选给药方式。常见的吸入给药制剂包括压力定量吸入剂、干粉吸入剂和雾化吸入剂。与前两者相比,雾化吸入剂具有处方简单、剂量灵活性好、吸入效果受吸气模式影响较小等特点。并在最近十几年里取得了快速发展,由过去仅在医院使用逐渐向便携化、智能化发展。本文就目前几种主要雾化器的工作原理、研究现状及其临床应用进行综述。 Inhalation therapy is the first choice for the treatment of respiratory diseases,such as asthma and chronic obstructive pulmonary diseases(COPD).In clinic,the most common used dosage forms for inhaled drug administration are pressurized metered-dose inhalers(pMDI),dry powder inhalers(DPI) and nebulizers.Among them the nebulizers possess the advantages including simplified formulation,dosage adjustment and less impact by inhalation profiles.In recent decade,a significant progress of nebulizers has been made.It offers tremendous possibilities for the development of portable and smart nebulizers in future.This review discusses the operational principle,research status and clinical use of several major nebulizers.
出处 《世界临床药物》 CAS 2011年第5期316-320,I0001,I0002,共7页 World Clinical Drug
基金 上海市重点科技攻关专项资助(项目编号10dz2251400)
关键词 雾化吸入剂 喷射雾化器 超声雾化器 振动筛雾化器 nebulizer jet-nebulizer ultrasonic nebulizer vibrating mesh nebulizer
作者简介 王兆东,硕士研究生,专业方向:药物新剂型和新制剂研究。 通信作者:周建平,教授,从事药剂学研究。 金方,研究员,从事药物新剂型及其产业化研究。
  • 相关文献

参考文献34

  • 1Anderson PJ.History of aerosol therapy:liquid nebulization to MDIs to DPIs[J].Respir Care,2005,50(9):1139-1150.
  • 2Chatburn RL,McPeck M.A new system for understanding nebulizer performance[J].Respir Care,2007,52(8):1037-1050.
  • 3Rau JL,Ari A,Restrepo RD.Performance comparison of nebulizer designs:constant-output,breath-enhanced,and dosimetric[J].Respir Care,2004,49(2):174-179.
  • 4Leung K,Louca E,Coates AL.Comparison of breathenhanced to breath-actuated nebulizers for rate,consistency,and efficiency[J].Chest,2004,126(5):1619-1627.
  • 5Szefler SJ,Eigen H.Budesonide inhalation suspension:a nebulized corticosteroid for persistent asthma[J].J Allergy Clin Immunol,2002,109(4):730-742.
  • 6Geller DE,Pitlick WH,Nardella PA,et al.Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis[J].Chest,2002,122(1):219-226.
  • 7Deterding R,Retsch-Bogart G,Milgram L,et al.Safety and tolerability of denufosol tetrasodium inhalation solution,a novel P2Y2 receptor agonist:results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis[J].Pediatr Pulmonol,2005,39(4):339-348.
  • 8Deterding RR,Lavange LM,Engels JM.Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis[J].Am J Respir Crit Care Med,2007,176(4):362-369.
  • 9Boguslavskii YY,Eknadiosyants OK.Physical mechanism of the acoustic atomization of a liquid[J].Soy Phys Acoust,1969,15:14-21.
  • 10Sollner K.Experiments to demonstrate cavitation caused by ultrasonic waves[J].Trans Faraday Soc,1936,32:1537-1539.

同被引文献434

引证文献44

二级引证文献297

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部